Schmitt, Niclas http://orcid.org/0000-0003-2509-5459
Floca, Ralf O http://orcid.org/0000-0003-3218-3377
Paech, Daniel http://orcid.org/0000-0001-5755-6833
El Shafie, Rami A http://orcid.org/0000-0002-1355-7882
Neuberger, Ulf http://orcid.org/0000-0002-3085-3886
Bendszus, Martin http://orcid.org/0000-0002-9094-6769
Möhlenbruch, Markus A http://orcid.org/0000-0002-5075-704X
Vollherbst, Dominik F http://orcid.org/0000-0002-8992-4757
Funding for this research was provided by:
Universitätsklinikum Heidelberg
Article History
Received: 12 February 2021
Accepted: 15 March 2021
First Online: 14 April 2021
Conflict of interest
: N. Schmitt, R.O. Floca, D. Paech, R.A. El Shafie and U. Neuberger declare that they have no competing interests. D.F. Vollherbst has received travel support outside this work from MicroVention and Stryker GmbH & Co. M. Bendszus reports board membership: DSMB Vascular Dynamics, Boehringer; grants/grants pending: DFG, Hopp Foundation, Novartis, Siemens, Guerbet, Stryker, European Union; payment for lectures: Novartis, Teva, Bayer, Codman, Grifols, Merck. M.A. Möhlenbruch has received consulting fees, speaker fees, and travel support outside this work from Codman, Covidien/Medtronic, MicroVention, Phenox, and Stryker.